NCT00293488View on ClinicalTrials.gov

SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2008

Conditions
Lymphoma
Interventions
DRUG

polyamine analogue PG11047

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Progen Pharmaceuticals

INDUSTRY